Weight loss pill shows promise in new trial
A new weight loss medication, which can be offered by injection or tablet, can help patients lose a significant amount weight, studies suggest.
An early study have found that people who received higher doses of amycretin as a weekly jab lost 24.3% of their body weight after 36 weeks of treatment.
And initial trials assessing a tablet form of the drug also showed promising results, with patients taking daily tablets losing an average of 13.1% of their body weight after 12 weeks.
Weight loss jabs have been hailed as transformative by NHS leaders.
But injections come with additional work for over-stretched health services so tablet forms of medication may offer a new hope for the millions of people looking to lose weight.
It has been estimated that around 1.5 million Britons are having weight loss jabs, which have been either prescribed through specialist weight loss services or private prescriptions.
GPs will be able to dish out that jabs from next week.
Amycretin, made by Novo Nordisk, helps to control blood sugar and appetite by targeting two specific receptors in the body – GLP-1 and the amylin receptor.
An early trial in 125 adults testing weekly injections of amycretin, which has been published in The Lancet, found that those taking the highest dosage (60mg) lost 24.3% after 36 weeks of treatment.
It also showed signs in improving blood sugar levels.
Side effects included nausea and vomiting and were mostly mild to moderate and resolved by the end of treatment.
'These phase 1b/2a data support the potential of once-weekly subcutaneous amycretin as a therapeutic for people living with overweight or obesity,' the authors wrote.
'Amycretin appeared safe and tolerable, and there were significant reductions in body weight after 36 weeks of treatment.'
The second early trial, published in the same journal, assessed amycretin in tablet form in 144 people over 12 weeks.
There were mild to moderate side effects including loss of appetite, nausea and vomiting.
Researchers found that people taking the highest dose of 100mg per day, lost 13.1% of their body weight over four months.
The authors wrote: 'Amycretin effectively lowered body weight and improved metabolic and glycaemic parameters in people with overweight or obesity.
'Longer studies with more participants are warranted for evaluation of the safety and efficacy of amycretin in individuals living with obesity and type 2 diabetes, and to optimise the dosing regimen.'
The studies were also presented at the American Diabetes Association's Scientific Sessions in Chicago, in the US.
It comes as a separate study, which was published at the same meeting, examined the effects of weight loss jab Wegovy at higher doses.
Researchers found that giving patients 7.2mg of Wegovy, also known as semaglutide, once a week led to an average weight loss of 20.7%, with a third of participants losing 25% or more of their body weight after 72 weeks.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
an hour ago
- Bloomberg
Chinese Biotech Showcases Challenger to Eli Lilly's Obesity Drug
An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new challenger to blockbusters from Novo Nordisk A/S and Eli Lilly & Co. Hangzhou Sciwind Biosciences Co. said its drug, ecnoglutide, led to more than 15% weight loss after 48 weeks when given at the highest dose. Although the trial did not compare ecnoglutide directly with existing medicines, the results were very similar to what Lilly's Zepbound showed in previous China studies, Sciwind Chief Executive Officer Hai Pan said in an interview.
Yahoo
3 hours ago
- Yahoo
Weight loss in your 40s and 50s can help slash your chronic disease risk, researchers say
Working to lose weight in your 40s and 50s may help to reduce your risk of developing a chronic disease, a new study reveals. Researchers based in the U.K. and Finland say they found health benefits in people who lost an average of 6.5 percent of their body weight in early middle age and maintained that weight loss throughout a period of 12 to 35 years. Those benefits especially include a lessened risk for cardiovascular disease and diabetes as well as an overall lower risk of death from chronic disease. 'The benefits of lifestyle-based weight management are widely discussed even though studies have found it surprisingly difficult to demonstrate health benefits beyond the prevention of diabetes,' University of Helsinki professor Dr. Timo Strandberg said in a statement. Strandberg was the lead author of the study which was published recently in the journal JAMA Network Open, the open-access journal of the American Medical Association. To reach these conclusions, the study tracked and analyzed the health of 23,000 white Europeans who were between the ages of 30 and 50 years old using data from three studies, conducted from 1985 to 1988, from 1964 to 1973, and between 2000 and 2013. They sorted the participants into four groups: people with persistent healthy weight, people who were overweight but became a healthy weight, people who were healthy and became overweight, and people who were overweight the entire time. 'Measurement of weight and height was conducted at a time when surgical and pharmacological weight-loss interventions were nearly nonexistent,' the authors noted. The cause of weight loss was not assessed, but given the age of the participants and lack of diagnosed disease, it was more likely intentional than caused by severe chronic conditions or frailty.' In one study, a reduction in body mass from overweight to normal weight over six years in mid-life was tied to a lower risk of developing chronic diseases. There was also a 48 percent lower risk for chronic illness compared to those who remained overweight, which largely held even after excluding participants who developed diabetes during follow-up. Another study showed a 57 percent risk for chronic illness. A third study, with the longest follow-up period, showed that weight loss in mid-life was associated with a 19 percent reduction in overall mortality. 'I'm certain that overall prevention of overweight and obesity starting in early life is absolutely the best thing to do,' Stranberg told The Independent. 'Our study indirectly proves this by showing that persistent healthy weight over the life-course is best.' He said that he hopes the findings will inspire people to see that lifestyle changes can lead to a longer life. 'This is particularly important today as more people are overweight than when the collection of our research data began 35 years ago,' he said in the statement.
Fox News
4 hours ago
- Fox News
Grandfather's simple changes reversed pre-diabetes diagnosis that left him 'petrified'
A 66-year-old grandfather who exercised daily was stunned to learn he was pre-diabetic — and he says making one small change to his eating habits helped reverse it. Dance teacher Will McKechnie, from Lytham St Annes, Lancashire, told SWNS he had always considered himself healthy. At 5 feet 10 inches tall and 167 pounds, he wore a medium-sized shirt, danced seven times a week, and didn't think twice about his daily snacks: a chocolate bar and a bag of chips. "I honestly thought I was really fit and healthy," McKechnie said. But after undergoing a free screening for people over 60 in May 2023, a routine blood test showed that his average blood sugar level was 6.2% — an indicator of pre-diabetes, according to SWNS. McKechnie didn't find out until a year later, during an unrelated appointment, when his doctor reviewed the results. "I was so shocked and worried to hear I was pre-diabetic," he said. McKechnie continued, "When he said it wouldn't be reversible over 48, I was terrified. I was petrified at the idea that I might be starting to have poor health." Determined to turn things around, McKechnie made some major changes — not only in what he ate, but how. He cut out the nightly chocolate and chips, started eating whole, nutritious foods, and began chewing his food much more slowly. Now, his lunch — a wholemeal chicken sandwich — takes him 40 minutes to eat. "I just have a very occasional treat now, and much smaller," McKechnie told SWNS. His breakfast now consists of fruit, and a typical dinner includes boiled eggs, roasted peanuts, celery, cherry tomatoes, carrots and cucumber. By focusing on slower eating and more mindful food choices, McKechnie shed nearly 27 pounds, bringing him down to 142 pounds and a size small shirt. "I honestly thought I was really fit and healthy." He also lost two inches off his waist — and, more importantly, his blood sugar dropped to 5.9% within nine months, SWNS reported. "I'm very determined," McKechnie said. He added, "If I set my mind to doing something, I'll do it, and I'm going to get my blood sugar even lower." The grandfather of four said he no longer battles sugar cravings and doesn't feel the urge to rush into stores for a chocolate fix. He also stays busy caring for his 18-month-old grandson and teaching two dance classes a week. McKechnie, who quit smoking in 1986 and stopped drinking in 2012, believes everyone should be proactive about checking their health — even if they look healthy on the outside. "Even if you have to pay for it, it's worth getting your blood sugar checked routinely," he told SWNS, adding, "It's much, much better to find out." For more Health articles, visit According to SWNS, McKechnie now says he feels stronger than ever and has "enormous amounts of energy." "I'm so relieved I had that test. It has changed my life and made me so much fitter."
